|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Remarks: Exhibit 24-Power of Attorney Reflects the beneficial ownership of the reporting person at the time of his appointment as a reporting person of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS Ireland"), and does not include the securities acquired by the reporting person upon the consummation of the redomiciliation of STERIS plc, a public limited company organized under the laws of England and Wales, pursuant to a court-approved scheme of arrangement (the "Scheme") on March 28, 2019. The reporting person will file a Form 4 reflecting his acquisition of STERIS Ireland securities in connection with the consummation of the Scheme. |
| Signatures | ||
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney | 03/28/2019 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
Securities and Exchange Commission Washington, D.C. 20549
RE: STERIS plc
1933 Act and 1934 Act Filings
Authorized Representatives
Ladies and Gentlemen:
The above Company, a public limited company organized under the laws of
Ireland, is or will be the issuer of securities registered under Section 12
of the Securities Exchange Act of 1934. The undersigned confirms, as of the
date appearing opposite his/her signature, that each of the "Authorized
Representatives" named below is authorized on his/her behalf to sign such
statements (on Form 3, Form 4, Form 5, Form 144, Schedule 13G, Form ID (if
necessary) or otherwise, collectively, "Forms") with respect to securities of
the Company (the "Securities"), and to submit to the Securities and Exchange
Commission such Forms (including reports, notices, and other statements) with
respect to the Securities, as are required by the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934 as amended (collectively, the
"Acts"). The undersigned also confirms the authority of each of the Authorized
Representatives to do and perform, on his/her behalf, any and all acts and
things with respect to the Securities requisite or necessary to assure
compliance by the undersigned with the filing requirements of the Acts.
This authority revokes all prior authorities with respect to the Securities
previously executed by the undersigned including but not limited to any such
authorities filed with or given to the Commission by the undersigned. This
authority contained herein shall remain in full force and effect until the
undersigned is no longer required to file Forms with respect to the
undersigned's holdings of and transactions in the Securities, unless earlier
revoked by the undersigned in a signed writing delivered to the Authorized
Representatives.
Authorized Representatives
Patricia Comai
Judith A. Hunter
Julia Kipnis
Rebecca A. Nichols
Ronald E. Snyder
Michael J. Tokich
J. Adam Zangerle
The undersigned acknowledges that the foregoing Authorized Representatives, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to
comply with the Acts. Additionally, although pursuant to this authority, the
Authorized Representatives will use commercially reasonable efforts to timely
and accurately file the required Forms on behalf of the undersigned, the
Authorized Representatives do not represent or warrant that they will be able
to in all cases timely and accurately file such Forms on behalf of the
undersigned due to various factors and the undersigned and the Authorized
Representatives' need to rely on others forinformation, including the
undersigned and brokers of the undersigned.
Dated: March 18, 2019 By: /s/ Dr. Mohsen M. Sohi
Signature
Dr. Mohsen M. Sohi
Printed Name